Five Prime Therapeutics, Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced total revenue was USD 2.048 million compared to USD 2.984 million a year ago. Operating loss was USD 33.110 million compared to USD 37.170 million a year ago. Net loss was USD 26.423 million compared to USD 36.069 million a year ago. Basic loss per share from continuing operations was USD 0.74 compared to USD 1.03 a year ago. For the nine months, total revenue was USD 13.886 million compared to USD 11.664 million a year ago. Operating loss was USD 70.887 million compared to USD 109.839 million a year ago. Net loss was USD 63.476 million compared to USD 105.845 million a year ago. Basic loss per share from continuing operations was USD 1.79 compared to USD 3.03 a year ago.